Healthcare

The numbers tell a stark story of transition. BioNTech’s Covid vaccine revenue is sliding toward a projected €2.0-2.3 billion for...

The gap between Siemens Healthineers’ strategic ambitions and its stock market performance has rarely been wider. While the medical technology...

The telehealth operator Hims & Hers is navigating one of its most turbulent periods yet, caught between a costly strategic...

ImmunityBio has pulled off a remarkable feat in the Middle East, getting its immunotherapy ANKTIVA onto the Saudi Arabian market...

Siemens Healthineers made a splash at Berlin’s DMEA healthcare conference this week, unveiling an ambitious artificial-intelligence strategy and a high-profile...

Siemens is threading a needle between high-tech expansion and corporate simplification, laying out fresh details on both its deepening ties...

Redcare Pharmacy's stock has clawed back from a March low of 31 euros, now trading around 53 euros, yet it...

Novo Nordisk shares, trading near 33 euros, reflect a market grappling with the pharmaceutical giant's dual narrative. While the company...

Investors in Siemens Healthineers are bracing for a pivotal quarterly report, seeking signs that the German medical technology giant can...

The appointment of a Silicon Valley artificial intelligence expert as its new technology chief underscores Siemens Healthineers' ambitious digital health...